Surgical Imaging Market

The global surgical imaging market is to be worth more than USD 4 billion by 2033.

Surgical imaging is expecting a boost in the future market due to newer technologies making it more convenient, a rise in the geriatric population, a rise in road accidents, and increasing utilization for cancer detection. As per current analysis, Road accidents and the aging population collectively boost orthopedic and trauma care in Hospitals, thus increasing the need for surgical imaging techniques. Advanced surgical imaging techniques have made them more convenient, with lesser radiation dose, minimal invasion, improved visual quality, and more portability. Recent researchers have also developed and utilized specific optical techniques that assisted in detecting cancers by locating tumor cells. Integration of AI has also added a new aspect to surgical imaging. AI was recently utilized by the fast MRI initiative established by NYU Langone Health and Meta AI Research to predict the rest of the MRI image scan by using little initial information. Research experts are also looking forward to the integration of 3-D technology with surgical imaging to give highly improved visual output. Visual Data can be interpreted using AI to predict surgical outcomes.

Companies in the surgical imaging sector are expanding their global footprint through mergers, collaboration, acquisition, long-term contracts, and service agreements. For example, GE HealthCare announced a deal to buy IMACTIS, a pioneer in the fast growing field of computed tomography (CT) interventional guiding across a wide range of care areas. Through GE HealthCare's vast installed base and worldwide scale, this acquisition will give enormous future expansion potential for the IMACTIS CT-Navigation system. Furthermore, industry stakeholders make significant investments in R&D to launch new and innovative solutions that assist operational integration at different levels.

According to the CXOs and primary research conducted, COVID-19 had a significant impact on people's stress and disease states. Cardiovascular risks were significantly elevated, and the entire pandemic saw a surge in patient imaging requirements. COVID-19 drastically changed the scenario of hospitals and pharmacists by pressuring more needs of medicines and medical devices. The COVID-19 pandemic made extensive use of lung imaging to track the infection and thus aided doctors in planning treatment accordingly.

The surgical imaging market is analyzed across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. In line with the studied region, the Asia-Pcific region will witness the highest market share, followed by Europe, North America, Latin America, and Middle East & Africa. Quick adoption of new technologies, support by researchers and the government towards integration of AI with surgical imaging, and the presence of major industry players within the region are primary factors supporting market potential within the Asia-Pacific region. The major companies operating within the market are Agilent Technologies, Inc., Basler AG, BPL Medical Technologies, General Electric, Koninklijke Philips N.V., Medtronic, Siemens Healthcare GmbH, Shimadzu Corporation, Toshiba Corporation, and OrthoScan Inc.